These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35497873)

  • 1. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis.
    Yan Z; Yang K; Tang X; Bi Y; Ding Y; Deng M; Xia D; Zhao Y; Chen T
    J Immunol Res; 2022; 2022():3851604. PubMed ID: 35497873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
    Ren J; Li G; Zhao W; Lin L; Ye T
    World J Gastroenterol; 2016 Apr; 22(15):3962-8. PubMed ID: 27099439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
    Liang L; Zhao L; Wang Y; Wang Y
    Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
    Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
    Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.
    Guan M; Zhou Y; Zhu QL; Liu Y; Bei YY; Zhang XN; Zhang Q
    Nanomedicine; 2012 Oct; 8(7):1172-81. PubMed ID: 22321383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro.
    Wang Y; Xu M; Di ZH; Zhang J; Mao XQ; Sun HB
    J Cancer Res Ther; 2015; 11(4):818-22. PubMed ID: 26881524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norcantharidin-Encapsulated C60-Modified Nanomicelles: A Potential Approach to Mitigate Cytotoxicity in Renal Cells and Simultaneously Enhance Anti-Tumor Activity in Hepatocellular Carcinoma Cells.
    Ding Z; Xu B; Zhang H; Wang Z; Sun L; Tang M; Ding M; Zhang T; Shi S
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma.
    Jiang S; Li M; Hu Y; Zhang Z; Lv H
    Carbohydr Polym; 2018 Oct; 197():194-203. PubMed ID: 30007605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro].
    Liu Y; Zahng J; You Z; Liao H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):824-8. PubMed ID: 25108435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin.
    Zhang Z; Yang L; Hou J; Xia X; Wang J; Ning Q; Jiang S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S630-S640. PubMed ID: 30449176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
    Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
    Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
    Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q
    Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
    Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells.
    Chang C; Zhu YQ; Mei JJ; Liu SQ; Luo J
    J Exp Clin Cancer Res; 2010 Nov; 29(1):145. PubMed ID: 21059274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.
    Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W
    J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin.
    Xie MH; Ge M; Peng JB; Jiang XR; Wang DS; Ji LQ; Ying Y; Wang Z
    Pharm Dev Technol; 2019 Jun; 24(5):623-629. PubMed ID: 30457414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atg5 siRNA inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma.
    Xiong X; Wu M; Zhang H; Li J; Lu B; Guo Y; Zhou T; Guo H; Peng R; Li X; Tian Q; Wang Y
    Int J Oncol; 2015 Oct; 47(4):1321-8. PubMed ID: 26240015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer.
    Li XY; Guan QX; Shang YZ; Wang YH; Lv SW; Yang ZX; Wang R; Feng YF; Li WN; Li YJ
    World J Gastroenterol; 2021 Jul; 27(26):4208-4220. PubMed ID: 34326620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on anti-hepatocarcinoma effect, pharmacokinetics and tissue distribution of carboxymethyl chitosan based norcantharidin conjugates.
    Chi J; Jiang Z; Chen X; Peng Y; Liu W; Han B; Han B
    Carbohydr Polym; 2019 Dec; 226():115297. PubMed ID: 31582090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.